Followers | 49 |
Posts | 1301 |
Boards Moderated | 0 |
Alias Born | 03/05/2014 |
Wednesday, April 15, 2020 10:07:12 PM
As an aside--while having the advantage of being plentiful, as you know, there is also growing negative evidence that adipose-derived SC's can increase adipocytes as homeostatic adipogenesis is impaired (entropic), and resultant visceral obesity substantially affects the risk of heart failure in these high-risk individuals; diabetes/diabetics may also be of concern.
Moreover, the thing is (and you should know the details), in November the adipose cells should be mostly eliminated by the new FDA regulations. Centeno doesn't even have the quality of labs they will be requiring that PRED does. Bone marrow cells will still be allowed, but cells derived from umbilical (Wharton's jelly) and amniotic fluid much better and rich in cells. Centeno only does adipose, and primarily bone marrow. Once adipose is gone, all he has is bone marrow, while the OA studies are showing great results for WJ (including the buried PRED pilot). So--he want's to kill PRED if he can, and that is what he's doing. He knows a COVID contract would give them a huge boost (aside from his short position) and is really hoping for failure.
I just hope he doesn't have ears in the FDA like he appears to in the OTC/Nas.
"Do just once what others say you can't do, and you will never pay attention to their limitations again."
--Captain James Cook
FEATURED DaBaby and Stunna 4 Vegas's "NO DRIBBLE" Joins Music Licensing, Inc.'s Portfolio • Jun 7, 2024 10:15 AM
Mushrooms Inc. (OTC: MSRM) Announces Significant Share Buy Back by the Board Director and New Strategic Initiatives. • MSRM • Jun 5, 2024 1:32 PM
Hydromer Announces Launch of HydroThrombX Medical Device Coating Technology • HYDI • Jun 5, 2024 10:24 AM
Dr. Michael Dent Finances $1 Million to Drive HealthLynked's Healthcare Transformation • HLYK • Jun 5, 2024 8:00 AM
Avant Technologies Enters Binding LOI to Purchase Dozens of High-Performance, Immersible, AI-Powered Servers • AVAI • Jun 5, 2024 8:00 AM
IQST - iQSTEL Announces $290 Million 2024 Annual Revenue Forecast • IQST • Jun 4, 2024 1:43 PM